Literature DB >> 19932491

Angiotensinogen polymorphisms and acquired atrial fibrillation in Chinese.

Qun-Shan Wang1, Yi-Gang Li, Xing-Dong Chen, Jie-Fei Yu, Jun Wang, Jian Sun, Shang-Biao Lu, Li Jin, Xiao-Feng Wang.   

Abstract

Genetic predisposition may be underlying the prevalence of acquired atrial fibrillation (AF). We investigated the association between polymorphism in angiotensinogen (AGT) and angiotensin-converting enzyme gene and risk of acquired AF in a pair-matched case-control study conducted in Chinese Hans. We selected 9 single nucleotide polymorphisms (SNPs) in the AGT gene and 3 SNPs in the angiotensin-converting enzyme gene using a tagging-SNP strategy. We observed significant association between tagging-SNP rs699 (M235T), located in exon 2 of the AGT gene, and AF. The AA genotype of rs699 increased the risk of AF by 70% (95% confidence interval, 1.01-2.85; P = .044) under a recessive model (AA vs AG + GG). The significance remained after controlling for covariates age, smoking, body mass index, hypertension, diabetes, and left atrial dimension, with an increased risk of AF by 90% (95% confidence interval, 1.04-3.46; P = .036). We provide evidence that polymorphism in AGT gene may confer predisposition to acquired atrial fibrillation in Chinese Hans. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19932491     DOI: 10.1016/j.jelectrocard.2009.09.009

Source DB:  PubMed          Journal:  J Electrocardiol        ISSN: 0022-0736            Impact factor:   1.438


  6 in total

Review 1.  Genetics of atrial fibrillation: implications for future research directions and personalized medicine.

Authors:  Steven A Lubitz; Cevher Ozcan; Jared W Magnani; Stefan Kääb; Emelia J Benjamin; Patrick T Ellinor
Journal:  Circ Arrhythm Electrophysiol       Date:  2010-06

2.  AT1 mutations and risk of atrial fibrillation based on genotypes from 71,000 individuals from the general population.

Authors:  Sarah C W Marott; Børge G Nordestgaard; Gorm B Jensen; Anne Tybjaerg-Hansen; Marianne Benn
Journal:  Br J Clin Pharmacol       Date:  2013-07       Impact factor: 4.335

3.  Interleukin-6 promoter polymorphisms and susceptibility to atrial fibrillation in elderly Han Chinese patients with essential hypertension.

Authors:  Jing Li; Jie Song; Min-Hui Jiang; Jin-Guo Zheng; Shu-Ping Gao; Jian-Hua Zhu; Min Pan
Journal:  J Interferon Cytokine Res       Date:  2012-08-27       Impact factor: 2.607

Review 4.  Personalized medicine and atrial fibrillation: will it ever happen?

Authors:  Steven A Lubitz; Patrick T Ellinor
Journal:  BMC Med       Date:  2012-12-04       Impact factor: 8.775

5.  Assessment of two missense polymorphisms (rs4762 and rs699) of the angiotensinogen gene and stroke.

Authors:  Hyun-Kyung Park; Myung-Chun Kim; Sung-Min Kim; Dae Jean Jo
Journal:  Exp Ther Med       Date:  2012-01-11       Impact factor: 2.447

6.  Conditional Up-Regulation of SERCA2a Exacerbates RyR2-Dependent Ventricular and Atrial Arrhythmias.

Authors:  Bin Liu; Qing Lou; Heather Smith; Florencia Velez-Cortes; Wolfgang H Dillmann; Björn C Knollmann; Antonis A Armoundas; Sándor Györke
Journal:  Int J Mol Sci       Date:  2020-04-05       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.